Results 251 to 260 of about 488,008 (333)
Novel inferior gluteal artery access for successful type 2 endoleak embolization enabling the access site hemostasis by manual compression: A case report. [PDF]
Ogawa R +7 more
europepmc +1 more source
The graphical abstract outlines the progressive development and impact of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). Technological Evolution illustrates the transition from brachytherapy with single‐dose, LDR/HDR schedules to fractionated radiotherapy, three‐dimensional conformal radiotherapy (3DCRT) and Gamma Knife ...
Jing Zhang +10 more
wiley +1 more source
Characterization of Ligand Binding in Human Serum Albumin from Atomistic Energy Transfer Simulations. [PDF]
Ergün Ö +4 more
europepmc +1 more source
Abstract Background The optimal design for care delivery in Parkinson's disease (PD) that addresses changing needs of the lived experience is unclear. There is a critical need for care models to be implemented and transferable across diverse healthcare systems with agility.
Deepa Dash +34 more
wiley +1 more source
Investigating within-host population diversity of Cryptosporidium parvum using BlooMine. [PDF]
Morris AV +3 more
europepmc +1 more source
ABSTRACT Respiratory syncytial virus (RSV) is a common virus that causes respiratory infections, posing a serious threat, particularly to infants, the elderly, and individuals with compromised immune systems. As the leading cause of lower respiratory tract infections (LRTIs) in infants, RSV is responsible for millions of cases worldwide each year.
Jie Shi +6 more
wiley +1 more source
Pharmacological Effects and Mechanisms of Tanshinone IIA in Bone Injury Repair. [PDF]
Hu W +6 more
europepmc +1 more source
Targeting a nucleotide‐sensitive groove on Hsp70 that binds the Bim BH3 helix, we integrate structures, biophysics, and SAR from peptides, fragments, and phenalene‐dicarbonitrile “wedges.” These disrupt the Hsp70–Bim complex with sub‐µM cellular engagement and in vivo activity while sparing Hsp90/mortalin.
Emadeldin M. Kamel +5 more
wiley +1 more source

